Bio-Rad (BIO) Posts Q3 EPS of $1.38, Tops Estimates
BIO Hot Sheet
Revenue Growth %: +0.2%Financial Fact:
Net income per share diluted attributable to Bio-Rad: 1.09
Today's EPS Names:
BRLI, TLB, TNP, More
Bio-Rad Laboratories, Inc. (NYSE: BIO) reports Q3 EPS of $1.38, versus the analyst estimate of $1.06. Revenue for the quarter was $461.10 million, which compares to the estimate of $435.62 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 7c; Guides Q3 Below the Street, Raises FY12 Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
